Control of myogenic differentiation by cellular oncogenes

Michael D. Schneider, Eric N. Olson

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The establishment of a differentiated phenotype in skeletal muscle cells requires withdrawal from the cell cycle and termination of DNA synthesis. Myogenesis can be inhibited by serum components, purified mitogens, and transforming growth factors, but the intracellular signaling pathways utilized by these molecules are unknown. Recent studies have confirmed a role for proteins encoded by cellular proto-oncogenes in transduction of growth factor effects that lead to cell proliferation. To test the contrasting hypothesis that cellular oncogenes might also regulate tissue-specific gene expression in developing muscle cells, myoblasts have been modified by incorporation of the cognate viral oncogenes, the corresponding normal or oncogenic cellular homologs, and chimeric oncogenes, whose expression can be induced reversibly. Regulation of the endogenous cellular oncogenes also has been examined in detail. Down-regulation of c-myc is not obligatory for myogenesis; rather, inhibitory effects of myc on muscle differentiation are contingent on sustained proliferation. In contrast, activated src and ras genes block myocyte differentiation directly, through a mechanism that is independent of DNA synthesis and is rapidly reversible, resembling the effects of inhibitory growth factors. The coordinate regulation of diverse tissue-specific gene products including muscle creatine kinase, nicotinic acetylcholine receptors, sarcomeric proteins, and voltage-gated ion channels, raises the hypothesis that inhibitors such as transforming growth factor-β and ras proteins might exert their effects through a transacting transcriptional signal shared by multiple muscle-specific genes.

Original languageEnglish (US)
Pages (from-to)1-39
Number of pages39
JournalMolecular Neurobiology
Volume2
Issue number1
DOIs
StatePublished - Mar 1988

Fingerprint

Oncogenes
Muscle Cells
Muscle Development
Transforming Growth Factors
Proto-Oncogene Proteins
src Genes
MM Form Creatine Kinase
ras Proteins
Muscles
ras Genes
Myoblasts
DNA
Nicotinic Receptors
Ion Channels
Mitogens
Genes
Intercellular Signaling Peptides and Proteins
Cell Cycle
Skeletal Muscle
Down-Regulation

Keywords

  • differentiation
  • growth factors
  • ion channels
  • muscle creatine kinase
  • myc
  • myogenesis
  • Oncogene
  • ras
  • skeletal muscle cells
  • src

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Control of myogenic differentiation by cellular oncogenes. / Schneider, Michael D.; Olson, Eric N.

In: Molecular Neurobiology, Vol. 2, No. 1, 03.1988, p. 1-39.

Research output: Contribution to journalArticle

@article{15ffecaa545c47a9b6a5e7a53c928ead,
title = "Control of myogenic differentiation by cellular oncogenes",
abstract = "The establishment of a differentiated phenotype in skeletal muscle cells requires withdrawal from the cell cycle and termination of DNA synthesis. Myogenesis can be inhibited by serum components, purified mitogens, and transforming growth factors, but the intracellular signaling pathways utilized by these molecules are unknown. Recent studies have confirmed a role for proteins encoded by cellular proto-oncogenes in transduction of growth factor effects that lead to cell proliferation. To test the contrasting hypothesis that cellular oncogenes might also regulate tissue-specific gene expression in developing muscle cells, myoblasts have been modified by incorporation of the cognate viral oncogenes, the corresponding normal or oncogenic cellular homologs, and chimeric oncogenes, whose expression can be induced reversibly. Regulation of the endogenous cellular oncogenes also has been examined in detail. Down-regulation of c-myc is not obligatory for myogenesis; rather, inhibitory effects of myc on muscle differentiation are contingent on sustained proliferation. In contrast, activated src and ras genes block myocyte differentiation directly, through a mechanism that is independent of DNA synthesis and is rapidly reversible, resembling the effects of inhibitory growth factors. The coordinate regulation of diverse tissue-specific gene products including muscle creatine kinase, nicotinic acetylcholine receptors, sarcomeric proteins, and voltage-gated ion channels, raises the hypothesis that inhibitors such as transforming growth factor-β and ras proteins might exert their effects through a transacting transcriptional signal shared by multiple muscle-specific genes.",
keywords = "differentiation, growth factors, ion channels, muscle creatine kinase, myc, myogenesis, Oncogene, ras, skeletal muscle cells, src",
author = "Schneider, {Michael D.} and Olson, {Eric N.}",
year = "1988",
month = "3",
doi = "10.1007/BF02935631",
language = "English (US)",
volume = "2",
pages = "1--39",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Control of myogenic differentiation by cellular oncogenes

AU - Schneider, Michael D.

AU - Olson, Eric N.

PY - 1988/3

Y1 - 1988/3

N2 - The establishment of a differentiated phenotype in skeletal muscle cells requires withdrawal from the cell cycle and termination of DNA synthesis. Myogenesis can be inhibited by serum components, purified mitogens, and transforming growth factors, but the intracellular signaling pathways utilized by these molecules are unknown. Recent studies have confirmed a role for proteins encoded by cellular proto-oncogenes in transduction of growth factor effects that lead to cell proliferation. To test the contrasting hypothesis that cellular oncogenes might also regulate tissue-specific gene expression in developing muscle cells, myoblasts have been modified by incorporation of the cognate viral oncogenes, the corresponding normal or oncogenic cellular homologs, and chimeric oncogenes, whose expression can be induced reversibly. Regulation of the endogenous cellular oncogenes also has been examined in detail. Down-regulation of c-myc is not obligatory for myogenesis; rather, inhibitory effects of myc on muscle differentiation are contingent on sustained proliferation. In contrast, activated src and ras genes block myocyte differentiation directly, through a mechanism that is independent of DNA synthesis and is rapidly reversible, resembling the effects of inhibitory growth factors. The coordinate regulation of diverse tissue-specific gene products including muscle creatine kinase, nicotinic acetylcholine receptors, sarcomeric proteins, and voltage-gated ion channels, raises the hypothesis that inhibitors such as transforming growth factor-β and ras proteins might exert their effects through a transacting transcriptional signal shared by multiple muscle-specific genes.

AB - The establishment of a differentiated phenotype in skeletal muscle cells requires withdrawal from the cell cycle and termination of DNA synthesis. Myogenesis can be inhibited by serum components, purified mitogens, and transforming growth factors, but the intracellular signaling pathways utilized by these molecules are unknown. Recent studies have confirmed a role for proteins encoded by cellular proto-oncogenes in transduction of growth factor effects that lead to cell proliferation. To test the contrasting hypothesis that cellular oncogenes might also regulate tissue-specific gene expression in developing muscle cells, myoblasts have been modified by incorporation of the cognate viral oncogenes, the corresponding normal or oncogenic cellular homologs, and chimeric oncogenes, whose expression can be induced reversibly. Regulation of the endogenous cellular oncogenes also has been examined in detail. Down-regulation of c-myc is not obligatory for myogenesis; rather, inhibitory effects of myc on muscle differentiation are contingent on sustained proliferation. In contrast, activated src and ras genes block myocyte differentiation directly, through a mechanism that is independent of DNA synthesis and is rapidly reversible, resembling the effects of inhibitory growth factors. The coordinate regulation of diverse tissue-specific gene products including muscle creatine kinase, nicotinic acetylcholine receptors, sarcomeric proteins, and voltage-gated ion channels, raises the hypothesis that inhibitors such as transforming growth factor-β and ras proteins might exert their effects through a transacting transcriptional signal shared by multiple muscle-specific genes.

KW - differentiation

KW - growth factors

KW - ion channels

KW - muscle creatine kinase

KW - myc

KW - myogenesis

KW - Oncogene

KW - ras

KW - skeletal muscle cells

KW - src

UR - http://www.scopus.com/inward/record.url?scp=0023967593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023967593&partnerID=8YFLogxK

U2 - 10.1007/BF02935631

DO - 10.1007/BF02935631

M3 - Article

C2 - 3077064

AN - SCOPUS:0023967593

VL - 2

SP - 1

EP - 39

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 1

ER -